The implementation of cold chain approach at transportation and storage of immunobiological preparations.

In the modern conditions of the coronavirus pandemic, the issue of transportation of immunobiological drugs is particularly actual, since control measures in this direction provide for supply of vaccines to different states, that naturally involves duration of transportation and compliance with certain established temperature regime at all stages of logistics chain, violation of which results in loss of pharmaceutical properties by drugs. The analysis demonstrated that currently transportation of immunobiological drugs is carried out within the framework of cold chain approach, which establishes mandatory compliance with temperature range of storage and transportation. Thus, the most important issue is control of compliance with temperature regime, which requires appropriate technical equipment at all levels of cold chain, ensuring fixation of detected violations.

[PROBLEMS OF REGULATORY AND LEGAL SUPPLY OF DRUGS CONTAINING NARCOTIC AND PSYCHOTROPIC SUBSTANCES OF OVERSEAS VESSEL].

In the context of the COVID-19 pandemic, the issue of protecting the vital functions of crew members on ship's board in conditions of a long voyage and stay in a confined space is urgent. In addition, excluding cases of infection with a new coronavirus infection, one must not forget about the readiness to provide first and subsequent medical assistance in case of urgent need to any crew member, and this can sometimes be done only by using drugs containing narcotic drugs and psychotropic substances in treatment or medical care. The analysis carried out indicates that there is no normative legal regulation of the composition of a first-aid kit in the Russian Federation, and many of the available international documents are for the most part advisory in nature. In this regard, the article carried out a detailed analysis of the regulatory framework governing the procedure for providing ships for overseas navigation with drugs, including those containing narcotic drugs and psychotropic substances, to protect the health of crew members of sea vessels in the context of the spread of COVID-19 and formulated the appropriate conclusions and recommendations.